Parkinsonism—Drug Treatment: Part I

M. J. Berg,B. Ebert,D. Willis,T. Høst,R. Fincham,D. Schottelius
DOI: https://doi.org/10.1177/10600280870211P101
1987-01-01
Drug Intelligence & Clinical Pharmacy
Abstract:The purpose of this two-part review is to explain current drug treatment in part I and discuss investigational drug therapy and miscellaneous drugs in the management of parkinsonism in part II. The medical approach to this disease is still based on the imbalance between a deficiency of dopamine and a functional increase in acetylcholine. Anticholinergic agents are used to treat the tremors in the early stages of the disease.
What problem does this paper attempt to address?